Immunofluorescence confocal microscopy of porcine corneas following collagen cross-linking treatment with riboflavin and ultraviolet A.

PURPOSE: To assess ultrastructural stromal modifications in porcine corneas after riboflavin and ultraviolet A (UVA) exposure using immunofluorescence confocal imaging. METHODS: Twenty-five freshly enucleated porcine eyes were enrolled in the study. Five eyes served as control (group I). Twenty eyes had their epithelium removed (groups I, II, IV, and V) and five eyes had their epithelium intact (group III). Groups II and III were cross-linked with riboflavin 0.1% solution (10 mg riboflavin-5-phosphate in 10 mL 20% dextran-T-500) and exposed to UVA (365 nm, 3 mW/cm2) for 30 minutes. Group IV included five eyes soaked with riboflavin without posterior irradiation, and group V included five eyes irradiated, without previous exposure to riboflavin. Ultra-thin sections (8 microm) of the corneas were stained with anti-collagen I and DAPI and their fluorescence was revealed under confocal microscopy. RESULTS: Only the cross-linked corneas (group II) showed a pronounced, highly organized anterior fluorescence zone of 182.5 +/- 22.5 microm. Using DAPI staining, an anterior and concentrated displacement of cell nuclei due to collagen compaction was observed after crosslinking (group II). No structural changes were observed in all other groups. CONCLUSIONS: The cross-linking treatment effect can be directly visualized using confocal fluorescence imaging, allowing for a quantitative analysis. Cross-linked corneas showed a pronounced and limited anterior zone of organized collagen fibers, which was not observed in the other groups. Treatment of the cornea with riboflavin and UVA without previous deepithelialization did not induce any cross-linking effect. Consequently, to facilitate diffusion of riboflavin throughout the corneal stroma, the epithelium should be removed as an important initial step in the treatment.

Higher-order aberrations of age-related cataract.

PURPOSE: To analyze higher-order aberrations induced by different types of lenticular opacities. SETTING: Federal University of São Paulo, São Paulo, Brazil. METHODS: One hundred thirty-eyes of 65 patients with bilateral cataract, classified according to the Lens Opacities Classification System III (LOCS III), had complete ophthalmic examinations, corneal topography (EyeSys Technologies), and wavefront analysis (LADARWave, Alcon Laboratories). Patients with cataracts that could not be measured by a Hartmann-Shack sensor or those with coexisting ocular disease were excluded. Higher-order aberrations were compared between the nuclear, cortical, and posterior subcapsular groups for statistical significance. RESULTS: One hundred five eyes of 65 patients were assessed. Twenty-eight eyes (23.33%) had predominantly nuclear opacification (NO1-NO6 and C1-2), and 13 (10.83%) had mainly cortical opacification (C1-4). Sixty-four eyes (65.83%) had a mixed pattern of LOCS III classification, which hindered the establishment of a correlation between the aberrometry and cataract type. Eighteen eyes that presented with dense posterior subcapsular cataract (P4-5) and 7 eyes with cortical C5 LOCS III classification were excluded. In eyes with nuclear opacification, the mean spherical aberration with a 6.0 mm pupil was 0.45 microm +/- 0.17 (SD) and the mean coma was 0.29 +/- 0.13 microm. In eyes with predominantly cortical cataract, the mean spherical aberration was 0.12 +/- 0.10 microm and the mean coma was 0.49 +/- 0.23 microm. The cortical cataract group had statistically significantly higher coma than the other groups (P<.001). The nuclear cataract group had statistically significantly higher spherical aberrations than the other groups (P<.001). CONCLUSIONS: Different types of early lenticular opacities induced different wavefront aberration profiles. Coma predominated in the cortical cataract group, and spherical aberration predominated in the nuclear cataract group.

Wavefront analysis and contrast sensitivity of aspheric and spherical intraocular lenses: a randomized prospective study.

PURPOSE: To compare visual performance, total and high order wavefront aberrations (coma, spherical aberration, and other terms), and contrast sensitivity in 120 eyes implanted with one monofocal aspheric intraocular lens (IOL) and two spherical IOLs. DESIGN: Randomized prospective study. METHODS: Sixty patients were randomized to receive three IOL types: Alcon AcrySofIQ (40 eyes), AcrySofNatural (40 eyes), and advanced medical optic (AMO)Sensar (40 eyes). Complete ophthalmologic examination including uncorrected visual acuity (UCVA), best-spectacle corrected visual acuity (BSCVA), corneal topography, and wavefront analysis were performed preoperatively, 30 days, and 90 days postoperatively. Pelli-Robson chart test and functional acuity contrast testing (FACT-Optec6500) were performed approximately 50 days after surgery. Statistical analyses were performed using analysis chi(2), analysis of variance (ANOVA), and multiple comparisons Tukey test. RESULTS: After 90 days, all eyes had postoperative BSCVA > or =20/32. The AcrySofIQ IOL showed statistically significant less induction of spherical aberration (P < .001) when compared with the AMOSensar and the AcrySofNatural IOLs. The AMOSensar presented significantly less spherical aberration then the AcrySofNatural (P < .05). The AcrySofIQ also had lower values of total and high-order aberration (HOA) (P < .05) when compared with the AMOSensar and the AcrySofNatural. The mean values of trefoil 9, coma, and HOA root mean square (RMS) decreased between one and three months (P < .001, P < .001, P = .023, P < .001, respectively) in all groups. Mean Pelli-Robson contrast sensitivity values in photopic condition were similar between the groups. The AcrySofIQ showed better results in 3cpd spatial frequency in mesopic condition using FACT-Optec 6500 (P = .008), although there were no statistical differences in photopic and mesopic with glare conditions.

Epithelial healing and visual outcomes of patients using omega-3 oral nutritional supplements before and after photorefractive keratectomy: a pilot study.

PURPOSE: To investigate the effect of omega-3 oral nutritional supplementation on corneal reepithelialization, visual acuity, and tear stability after photorefractive keratectomy (PRK). METHODS: This is a prospective, randomized, single-blinded controlled therapeutic trial using omega-3 oral nutritional supplements (TheraTears Nutrition for Dry Eyes; Advanced Vision Research-Akorn, Ann Arbor, MI) conducted at our center. Eighteen healthy patients with refractive error between -1 and -8 diopters were recruited and had bilateral PRK. The treatment group (n = 9 subjects) received omega-3 2 weeks before surgery through 1 month after PRK. The control group (n = 9 subjects) was not given omega-3. Epithelial defects were photographed on postoperative days 0 to 5. Reepithelialization (area in square millimeters) was assessed by fluorescein staining until healing. Tear breakup time (TBUT) and uncorrected distance visual acuity were measured at 1 week, and 1 and 3 months postoperatively. RESULTS: Epithelial defect in the treatment group eyes healed faster compared with that of the controls (P = 0.04). The treatment group eyes healed at an average rate of 1.19% [SD = 0.002; 95% confidence interval (CI), 1.04%-1.34%] per hour, versus 0.83% (SD = 0.0008; 95% CI, 0.77%-0.89%) for controls (Mann-Whitney rank-sum test, P < 0.001). The treatment group eyes maintained a significantly longer TBUT from week 1 through 3 months (mean = 9.52 seconds, SD = 0.81; 95% CI, 8.93-10.10), compared with the controls (mean = 5.52 seconds, SD = 0.81; 95% CI, 4.93-6.10; P < 0.001), and all reached 20/20 vision versus only 4 in the control group 1 month after surgery (P = 0.03). CONCLUSIONS: Omega-3 oral nutritional supplements decreased the average time for epithelial healing, and improved TBUT and visual acuity recovery in PRK. These findings suggested that omega-3 oral nutritional supplementation may be a beneficial adjunct therapy for PRK patients.

Corneal absorption of a new riboflavin-nanostructured system for transepithelial collagen cross-linking.

Corneal collagen cross-linking (CXL) has been described as a promising therapy for keratoconus. According to standard CXL protocol, epithelium should be debrided before treatment to allow penetration of riboflavin into the corneal stroma. However, removal of the epithelium can increase procedure risks. In this study we aim to evaluate stromal penetration of a biocompatible riboflavin-based nanoemulsion system (riboflavin-5-phosphate and riboflavin-base) in rabbit corneas with intact epithelium. Two riboflavin nanoemulsions were developed. Transmittance and absorption coefficient were measured on corneas with intact epithelia after 30, 60, 120, 180, and 240 minutes following exposure to either the nanoemulsions or standard 0.1% or 1% riboflavin-dextran solutions. For the nanoemulsions, the epithelium was removed after measurements to assure that the riboflavin had passed through the hydrophobic epithelium and retained within the stroma. Results were compared to de-epithelialized corneas exposed to 0.1% riboflavin solution and to the same riboflavin nanoemulsions for 30 minutes (standard protocol). Mean transmittance and absorption measured in epithelialized corneas receiving the standard 0.1% riboflavin solution did not reach the levels found on the debrided corneas using the standard technique. Neither increasing the time of exposure nor the concentration of the riboflavin solution from 0.1% to 1% improved riboflavin penetration through the epithelium. When using riboflavin-5-phosphate nanoemulsion for 240 minutes, we found no difference between the mean absorption coefficients to the standard cross-linking protocol (p = 0.54). Riboflavin nanoemulsion was able to penetrate the corneal epithelium, achieving, after 240 minutes, greater stromal concentration when compared to debrided corneas with the standard protocol (p = 0.002). The riboflavin-5-phosphate nanoemulsion diffused better into the stroma than the riboflavin-base nanoemulsion.

Effect of corneal epithelium on ultraviolet-A and riboflavin absorption.

PURPOSE: To determine if the corneal epithelium prevents the collagen cross-linking effect. Using immunofluorescence microscopy after CXL, we indirectly analyzed the role of the epithelium as ultraviolet-A (UVA) shield as well as a barrier to riboflavin penetration. METHODS: Fifteen freshly enucleated porcine eyes were divided into 3 groups. The corneal epithelium was kept intact in all groups. Five eyes served as control (Group 1). On group 2, eyes received tetracaine anesthetic drops and topical 0.1% riboflavin solution (10 mg riboflavin-5-phosphate in 10 mL 20% dextran-T-500). On Group 3, riboflavin was injected into the anterior chamber to allow penetration of the drug through the endothelium. Groups 2 and 3 were exposed to UVA (365 nm, 3 mW/cm(2)) for 30 minutes. Ultra-thin sections (8 µm) of the corneas were stained with anti-collagen type I and DAPI (4,6-diamidino-2-fenilindole dihydrocloride) and analyzed with fluorescence microscopy. RESULTS: Corneas treated with UVA irradiation and intracameral injection of riboflavin (Group 3) showed greater pattern of collagen organization compared to groups 1 (Control) and 2 (riboflavin and tetracaine eye drops). A yellow stromal staining, which represents the riboflavin diffusion into the stroma, was only observed in eyes injected with riboflavin into the anterior chamber. CONCLUSION: Using immunofluorescence microscopy in porcine corneas, we demonstrated that the corneal epithelium reduces the effectiveness of CXL by preventing the penetration of the drug and not by limiting the UVA transmittance. An inadequate intrastromal concentration of riboflavin may impair CXL effect.

[Ganciclovir 0.15% ophthalmic gel in the treatment of adenovirus keratoconjunctivitis]. / Uso de ganciclovir 0,15% gel para tratamento de ceratoconjuntivite adenoviral.

PURPOSE: To evaluate the efficacy and the toxicity of 0.15% ganciclovir gel in the treatment of adenoviral conjunctivitis and in preventing ocular complications after adenoviral conjunctivitis, such as corneal infiltrates and pseudomembranes. METHODS: Double blind, interventional and randomized clinical trial. Thirty-three patients with clinical diagnosis of adenoviral conjunctivitis with onset of symptoms for five or less days were randomized in two groups: Group 1 (treatment) with 19 patients used ganciclovir gel and Group 2 (control) with 14 patients used artificial tears without preservative. Patients answered a questionnaire of signs and symptoms and were submitted to an ophthalmologic exam. On the 6th and 10th days of treatment they answered the same questions and were re-examined by the same ophthalmologist. Signs and symptoms were compared. T Student, Mann-Whitney e Wilcoxon tests were used to statistical analysis. RESULTS: Trend of better response in the treatment group in relation of patients' perception, besides faster improvement of this group compared to the control group (p=0.26). There were lower transmission to the fellow eye (p=0.86) and to people living together (p=0.16) in the treatment group. No statistical difference related to signs and symptoms of conjunctivitis were found comparing both groups. We observed statistical difference in pain, itch and photophobia only in the treatment group, comparing each group alone. No toxicity and more tolerance of the ganciclovir were observed. There was no statistical difference in the ocular complications after conjunctivitis between both groups. CONCLUSIONS: This study showed trend of better and faster response of the signs and symptoms of the patients treated with ganciclovir compared with the control group, but with no statistical significant. These results need to be confirmed by additional studies, with more patients and longer follow-up. Clinical Trails.gov: NCT01349452.

Corneal asphericity and spherical aberration after refractive surgery.

PURPOSE: To evaluate changes in corneal asphericity (Q) and spherical aberrations after refractive surgery using Scheimpflug imaging. SETTING: University of California, San Diego, Shiley Eye Center, La Jolla, California, USA. DESIGN: Cohort study. METHODS: After wavefront-guided laser in situ keratomileusis, patients within ± 0.50 diopter of plano and with an uncorrected distance visual acuity of at least 20/20 were evaluated. The Q values and corneal spherical aberration Zernike values were obtained using Scheimpflug imaging preoperatively and 1 to 3 months postoperatively. RESULTS: The study enrolled 177 myopic eyes and 32 hyperopic eyes. The mean Q value was -0.28 ± 0.11 (SD) and -0.22 ± 0.15, respectively, preoperatively and +0.35 ± 0.44 and -0.64 ± 0.31, respectively, postoperatively. The asphericity change was highly correlated with preoperative spherical equivalent (r(2) = 0.81; P ≤ .001). The mean corneal spherical aberration was +0.21 ± 0.08 µm in myopic eyes and +0.36 ± 0.11 µm in hyperopic eyes preoperatively and +0.36 ± 0.17 µm and 0.00 ± 0.29 µm, respectively, postoperatively. The corneal spherical aberration changes were correlated with the amount of preoperative refractive error (r(2) = 0.34; P < .001). There was a tendency for Q values and spherical aberrations to become more positive after myopic ablation and more negative after hyperopic ablation. CONCLUSIONS: Myopic and hyperopic corrections induced changes in the Q value and spherical aberrations in opposite directions (ie, positive and negative, respectively). The changes depended on the magnitude of the refractive correction. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.

Effect of collagen cross-linking in stromal fibril organization in edematous human corneas.

PURPOSE: To assess structural stromal modifications after riboflavin and UV-A exposure in edematous human corneas. METHOD: Fourteen eyes with corneal edema were enrolled in the study. In the cross-linking (CXL) group, 7 corneal buttons were obtained from 6 patients who underwent penetrating keratoplasty (PK) 7-90 days after the CXL treatment. The control group was composed of 7 corneal buttons with bullous keratopathy. After the PK, stromal modifications were investigated using immunofluorescence in all corneal grafts. All patients had at least 3 months of corneal edema and were in the eye bank list waiting for keratoplasty. RESULTS: All corneas in the treated group showed a pronounced lamellar zone of collagen fibers highly organized in the anterior stroma, but there was not complete homogeneity between the samples. Corneas with advanced disease and stromal fibrosis were less compacted than ones with mild disease severity. Similarly, those ones that underwent PK 3 months after CXL also showed a decreased effect compared with those with a reduced time between the CXL and the PK. DAPI staining demonstrated a complete fragmentation of keratocytes nuclei in the anterior stroma in all treated corneas, which were absent in the control group. CONCLUSIONS: Our study showed an immediate effect of CXL with a limited long-term sustainability. Cross-linked corneas had a pronounced anterior zone of organized collagen fibers. Even the treated corneas with advanced bullous keratopathy and stromal fibrosis had histological evidence of collagen fibers organization, but this effect seems to be decreased compared with corneas in initial stages of the disease.

Effect of corneal epithelium on ultraviolet-A and riboflavin absorption / Efeito do epitélio na absorção corneana de raios ultravioleta-A e riboflavina

PURPOSE: To determine if the corneal epithelium prevents the collagen cross-linking effect. Using immunofluorescence microscopy after CXL, we indirectly analyzed the role of the epithelium as ultraviolet-A (UVA) shield as well as a barrier to riboflavin penetration. METHODS: Fifteen freshly enucleated porcine eyes were divided into 3 groups. The corneal epithelium was kept intact in all groups. Five eyes served as control (Group 1). On group 2, eyes received tetracaine anesthetic drops and topical 0.1 percent riboflavin solution (10 mg riboflavin-5-phosphate in 10 mL 20 percent dextran-T-500). On Group 3, riboflavin was injected into the anterior chamber to allow penetration of the drug through the endothelium. Groups 2 and 3 were exposed to UVA (365 nm, 3 mW/cm²) for 30 minutes. Ultra-thin sections (8 µm) of the corneas were stained with anti-collagen type I and DAPI (4,6-diamidino-2-fenilindole dihydrocloride) and analyzed with fluorescence microscopy. RESULTS: Corneas treated with UVA irradiation and intracameral injection of riboflavin (Group 3) showed greater pattern of collagen organization compared to groups 1 (Control) and 2 (riboflavin and tetracaine eye drops). A yellow stromal staining, which represents the riboflavin diffusion into the stroma, was only observed in eyes injected with riboflavin into the anterior chamber. CONCLUSION: Using immunofluorescence microscopy in porcine corneas, we demonstrated that the corneal epithelium reduces the effectiveness of CXL by preventing the penetration of the drug and not by limiting the UVA transmittance. An inadequate intrastromal concentration of riboflavin may impair CXL effect.

OBJETIVO: Determinar se o epitélio corneano pode impedir ou diminuir o efeito do tratamento com "cross-linking" (CXL). Por meio de microscopia por imunofluorescência, foi indiretamente analisado o efeito do epitélio como escudo aos raios ultravioleta-A (UVA), assim como barreia à penetração da riboflavina. MÉTODOS: Quinze olhos enucleados de porcos foram divididos em 3 grupos. O epitélio corneano foi mantido intacto em todos os grupos. Cinco olhos serviram como controle (Grupo 1). No grupo 2, os olhos foram instilados com colírio anestésico de tetracaína, assim como colírio de riboflavina 0,1 por cento (10 mg de riboflavina-5-fosfato em 10 ml de dextran 20 por cento T-500). No grupo 3, solução de riboflavina foi injetada na câmara anterior para permitir a penetração da droga através do endotélio. Os grupos 2 e 3 foram então expostos à radiação UVA (365 nm, 3 mW/cm²) por 30 minutos. Subsequentemente, cortes ultrafinos (8 µm) das córneas foram marcados com anticolágeno tipo I e DAPI (4,6-diamidino-2-fenilindole dihydrocloride) e analisados com microscópio de imunofluorescência. RESULTADOS: As córneas que receberam injeção intracameral de riboflavina e foram irradiadas com UVA (Grupo 3) mostraram um padrão maior de organização das fibras de colágeno em relação aos grupos 1 (Controle) e 2 (instiladas com colírio anestésico e de riboflavina). Macroscopicamente, a coloração amarelada do estroma, que representa a difusão da riboflavina, foi apenas observada nos olhos que receberam riboflavina intracameral. CONCLUSÃO: Foi demonstrado, através de microscopia por imunofluorescência em córneas de porcos, que o epitélio corneano íntegro diminui a efetividade do CXL por reduzir a penetração da riboflavina, e não por impedir a penetração dos raios UVA. Uma concentração intraestromal inadequada de riboflavina limita o efeito do tratamento.

Uso de ganciclovir 0,15 por cento gel para tratamento de ceratoconjuntivite adenoviral / Ganciclovir 0.15 percent ophthalmic gel in the treatment of adenovirus keratoconjuntivitis

OBJETIVOS: Determinar a efetividade e a toxicidade do ganciclovir 0,15 por cento gel no tratamento de ceratoconjuntivites adenovirais e na prevenção de complicações tais como infiltrados corneanos, membranas ou pseudomembranas conjuntivais. MÉTODOS: Ensaio clínico duplo-cego, intervencionista, randomizado. Os 33 pacientes com diagnóstico clínico de ceratoconjuntivite adenoviral com início dos sintomas há menos de cinco dias foram randomizados em dois grupos: Grupo 1 (tratamento) com 19 pacientes que usaram ganciclovir e Grupo 2 (controle) com 14 pacientes que usaram lágrima artificial sem conservante. Todos pacientes responderam a um questionário de sinais e sintomas e foram submetidos a um exame oftalmológico. No 6º dia de tratamento responderam ao mesmo questionário por telefone e no 10º dia foram reavaliados pelo mesmo examinador e responderam novamente ao questionário. Os sinais e sintomas foram comparados. Para análise estatística foi utilizado os testes T de Student, Mann-Whitney e Wilcoxon, com significância estatística p<0,05. RESULTADOS: Tendência de melhor resposta no grupo tratamento em relação à percepção pelos pacientes, além da melhora mais rápida desse grupo em relação ao grupo controle (p=0,26). Houve menor transmissão para o olho adelfo (p=0,86) e para pessoas do convívio (p=0,16) no grupo tratamento. Comparando os dois grupos não houve diferença estatística em relação aos sintomas e sinais da conjuntivite. Comparando isoladamente cada grupo entre o pré-tratamento e no decorrer do tratamento, observou-se melhora estatisticamente significativa da dor, prurido e fotofobia apenas no grupo tratamento. Ganciclovir não mostrou toxicidade e teve maior tolerância pelos pacientes. Não houve diferença significativa no aparecimento de complicações da conjuntivite entre os dois grupos. CONCLUSÕES: O estudo evidenciou uma tendência à melhora mais rápida dos sinais e sintomas dos pacientes tratados com ganciclovir em relação ao grupo ...

PURPOSE: To evaluate the efficacy and the toxicity of 0.15 percent ganciclovir gel in the treatment of adenoviral conjunctivitis and in preventing ocular complications after adenoviral conjunctivitis, such as corneal infiltrates and pseudomembranes. METHODS: Double blind, interventional and randomized clinical trial. Thirty-three patients with clinical diagnosis of adenoviral conjunctivitis with onset of symptoms for five or less days were randomized in two groups: Group 1 (treatment) with 19 patients used ganciclovir gel and Group 2 (control) with 14 patients used artificial tears without preservative. Patients answered a questionnaire of signs and symptoms and were submitted to an ophthalmologic exam. On the 6th and 10th days of treatment they answered the same questions and were re-examined by the same ophthalmologist. Signs and symptoms were compared. T Student, Mann-Whitney e Wilcoxon tests were used to statistical analysis. RESULTS: Trend of better response in the treatment group in relation of patients' perception, besides faster improvement of this group compared to the control group (p=0.26). There were lower transmission to the fellow eye (p=0.86) and to people living together (p=0.16) in the treatment group. No statistical difference related to signs and symptoms of conjunctivitis were found comparing both groups. We observed statistical difference in pain, itch and photophobia only in the treatment group, comparing each group alone. No toxicity and more tolerance of the ganciclovir were observed. There was no statistical difference in the ocular complications after conjunctivitis between both groups. CONCLUSIONS: This study showed trend of better and faster response of the signs and symptoms of the patients treated with ganciclovir compared with the control group, but with no statistical significant. These results need to be confirmed by additional studies, with more patients and longer follow-up. Clinical Trails.gov: NCT01349452.

Adesivo biológico de fibrina na mioescleropexia posterior em coelhos: estudo experimental / Fibrin biological adhesive for posterior mioscleral fixation of superior rectus muscles: an experimental study in rabbits

OBJETIVOS: 1. Verificar a capacidade de cola do adesivo biológico de fibrina quando utilizado para reduzir o arco de contato do músculo reto superior com a esclera de coelhos. 2. Comparar a redução da função do músculo reto superior tratado com a função do músculo reto superior contralateral, utilizado como controle. MÉTODOS: A amostra foi constituída por 30 coelhos, 60 olhos. Em cada coelho, realizou-se mioescleropexia posterior com adesivo biológico em um dos olhos (30 olhos), enquanto o outro serviu como controle (30 olhos). Todos os animais foram sacrificados após 60 dias pós-operatórios. Avaliaram-se a hipofunção muscular e o tamanho da aderência mioescleral produzida imediatamente pela cirurgia e após 60 dias. RESULTADOS: O coágulo de fibrina formou-se imediatamente à sua aplicação no músculo, e as fibras musculares apresentaram-se aderidas em poucos segundos à esclera. Todos os olhos operados com adesivo bio-lógico de fibrina demonstraram hipofunção muscular após 60 dias, quando comparada ao músculo contralateral. O tamanho do coágulo formado inicialmente, relacionado às medidas obtidas após 60 dias, demonstrou uma porcentagem de redução de 28,48 por cento e uma correlação ascendente e positiva (r=0,367204), porém fraca, elucidando a existência de múltiplas variáveis influenciando nessa redução. Não houve sinais de hiperemia, secreção conjuntival, ou qualquer outra complicação atribuída à cirurgia, ao final de 60 dias. CONCLUSAO: O adesivo biológico de fibrina provoca adesão músculo-escleral, encurtando o arco de contato, ocasionando a hipofunção desejada. A aplicação do adesivo facilita a mioescleropexia posterior, evitando a possibilidade de perfuração ocular.

Hipertensäo e retinopatia hipertensiva / Hypertension and hypertensive retinopathy

Objetivo: Avaliar a prevalência de retinopatia hipertensiva (RH) em pacientes hipertensos (controlados e näo controlados) e normotensos na populaçäo acima dos 40 anos do município de Piraquara. Correlacionar os casos de alteraçäo retiniana com o sexo, a raça e a idade do paciente. Métodos: Durante 1998 e 2000, foram examinados no Projeto Glaucoma da Universidade Federal do Paraná 1.954 pacientes. Destes, excluíram-se aqueles abaixo de 40 anos e os diabéticos, sendo que a populaçäo considerada para este estudo foi de 1.741 pacientes. O protocolo do projeto consiste de anamnese direcionada, aferiçäo da pressäo arterial (PA), glicemiaportiras reativas, PIO e fundoscopia direta e indireta. As alteraçöes fundoscópicas pertinentes a retinopatia hipertensiva foram estudadas segundo a classificaçäo de Gans e correlacionadas conforme mencionado anteriormente. Resultados: Dos 1.741 pacientes analisados, 669 (38,43 por cento) säo hipertensos, 645 (37,05 por cento) normotensos e 427 (24,53 por cento) suspeitos de hipertensäo arterial sistêmica (HAS). Foram encontrados 211 (12,12 por cento) pacientes com sinais de RH, sendo 136 (64,46 por cento) do sexo feminino e 75 (35,54 por cento) do sexo masculino; 134 (63,98 por cento) de 40 a 60 anos e 77 (36,02 por cento) com idade superior a 60 anos; predominando as raças branca (75,83 por cento) e negra (11,37 por cento). Do total de pacientes com RH, 154 (73 por cento) eram hipertensos, 17 (2,64 por cento) normotensos e 40 (9,37 por cento) suspeitos de HAS. Dentre os hipertensos com PA controlada, 12,2 por cento apresentavam sinais de retinopatia. Já dentre os hipertensos com PA näo controlada, 25,3 por cento apresentavam sinais da patologia. Conclusäo: A prevalência de RH foi maior nos hipertensos comparativamente aos normotensos e suspeitos de HAS (p<0,001, OR=5,32). Os pacientes negros (p<0,05 e OR= 1,67), os hipertensos com PA näo controlada (p<0,01, OR=2,44) e os acima de 60 anos (p<0,001, ORTl,85) apresentaram maiores chances de desenvolverem RH.

Terapia fotodinâmica com Verteporfirina na degeneração macular relacionada à idade / Photodynamic therapy with Verteporfirina for choroidal neovascularization caused by age related macular degeneration

A degeneração macular senil é a principal causa de cegueira legal em vários países do mundo ocidental e, atualmente, a maior causa de perda de visão em pessoas acima de 50 anos. Este trabalho foi realizado com a finalidade de determinar a segurança e a eficácia, alongo prazo, da terapia fotodinâmica associada à Verteporfirina em pacientes com degeneração macular relacionada à idade (DMRI). Oitenta e um pacientes com DMRI foram submetidos à injeção de Verteporfirina (Visudyne), com subsequente aplicação de laser com comprimento de onda de 690nm durante 83 segundos. Tais pacientes foram subdivididos em grupos de acordo com o padr-o angiográfico da membrana neovascular subretiniana (MNVSR) em: membranas clássicas ou predominantemente clássicas ou ocultas e analisados quanto à sua regressão ou não, bem como quanto à acuidade visual pré e pós-tratamento. Dos 81 olhos estudados, houve sinais de regressão em 79 (97,53 por cento) deles. Em 2 (2,47 por cento) pacientes, não houve regressão da membrana. Um deles possuía MNVSR com padrão angiográfico do tipo oculto e no outro a membrana era predominantemente clássica, porém muito espessa e extensa, não havendo alterações de suas características. Ocorreu recidiva em 39 (48,15 por cento) olhos. Houve melhoria da visão em 35 (43,21 por cento) pacientes; em 36 (44,44 por cento) pacientes manteve-se nos mesmos valores pré-tratamentos; e em 10 (12,34 por cento) houve piora da acuidade visual. O seguimento variou entre 24 e 36 meses. Através desse estudo vemos que a Terapia Fotodinâmica é um bom método para controle da degeneração macular relacionada à idade, principalmente quando a lesão possui componente clássico e não oculto

Terapia fotodinâmica da neovascularizaçäo coroideana na degeneraçäo macular relacionada à idade com verteporfirina / Photodynamic therapy with verteporfirin for choroidal neovascularization caused by age related macular degeneration

A degeneraçäo macular senil é a principalcausa de cegueira legal em vários países do mundo ocidental e, atualmente, a maior causa de perda de visäo em pessoas acima de 50 anos. Este trabalho foi realizado com a finalidade de determinar se a terapia fotodinâmica com Verteporfirina pode reduzir com segurança o risco de perda de visäo nos pacientes com neovascularizaçäo coroideana com Degeneraçäo Macular Relacionada à Idade (DMRI). Trinta e cinco pacientes com DMRI foram submetidos à injeçäo de Verteporfirina (Visudyne), com subseqüente aplicaçäo de laser, de comprimento de onda de 690 nm, durante 83 segundos. Tais pacientes foram analisados quanto à acuidade visual pré e pós-tratamento, bem como quanto à regressäo ou näo da membrana neovascular. Dos 35 olhos estudados, a Membrana Neovascular Subretiniana (MNVSR) mostrou sinais de regressäo em 29 (82,86 por cento) deles. Nestes olhos a membrana era do tipo clássica ou predominantemente clássica. Em 6 (17,14 por cento) pacientes, näo houve regressäo da membrana. Quatro deles possuíam MNVSR com padräo angiográfico do tipo oculto e em 2 olhos a membrana era predominantemente clássica, porém muito espessa e extensa, näo havendo alteraçöes de suas características. Ocorreu recidiva em 11 (31,42 por cento) olhos. Houve melhora da visäo em 18 (51,42 por cento) pacientes; em 14 (40 por cento) pacientes manteve-se nos mesmos valores pré-tratamento; e em 3 pacientes houve piora da acuidade visual.A través desse estudo vemos que a Terapia Fotodinâmica é um bom método para controle da degeneraçäo macular relacionada à idade, principalmente quando a lesäo possui componente clássico e näo oculto. O seguimento desses pacientes, entretanto, ainda é muito pequeno para que conclusöes de mais longo prazo possam ser tiradas